Plant sterols, cholesterol precursors and oxysterols: Minute concentrations—Major physiological effects

Journal of Steroid Biochemistry and Molecular Biology

Volumn 169, Issue , 2017, Pages 4-9

  Olkkonen, Vesa M ^a,b   Gylling, Helena ^c   Ikonen, Elina ^a,b  

^a MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cholesterol; Cholesterol precursor; Diagnostics; Disease mechanism; Oxysterol; Plant sterol

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; OXYSTEROL; PHYTOSTEROL; STANOZOLOL;

CIRCULATION; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; REVIEW; STEROL METABOLISM; STEROL SYNTHESIS; ANIMAL; CHEMISTRY; IMMUNE SYSTEM; INFLAMMATION; LIPID METABOLISM;

ANIMALS; BIOMARKERS; CHOLESTEROL; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LIPID METABOLISM; OXIDATIVE STRESS; OXYSTEROLS; PHYTOSTEROLS;

EID: 84951943312     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.12.026     Document Type: Review

References (44)

1. [1] Ikonen, E., Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9 (2008), 125–138.
2. [2] Maxfield, F.R., van Meer, G., Cholesterol, the central lipid of mammalian cells. Curr. Opin. Cell Biol. 22 (2010), 422–429.
3. [3] Olkkonen, V.M., Hynynen, R., Interactions of oxysterols with membranes and proteins. Mol. Aspects Med. 30 (2009), 123–133.
4. [4] Othman, R.A., Myrie, S.B., Jones, P.J., Non-cholesterol sterols and cholesterol metabolism in sitosterolemia. Atherosclerosis 231 (2013), 291–299.
5. [5] Ostlund McGill, R.E.J.B. Jr., Zeng, C.M., Covey, D.F., Stearns, J., Stenson, W.F., Spilburg, C.A., Gastrointestinal absorption and plasma kinetics of soy Delta (5)-phytosterols and phytostanols in humans. Am. J. Physiol. Endocrinol. Metab. 282 (2002), E911–E916.
6. [6] Sabeva, N.S., McPhaul, C.M., Li, X., Cory, T.J., Feola, D.J., Graf, G.A., Phytosterols differentially influence ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells. J. Nutr. Biochem. 22 (2011), 777–783.
7. [7] Escola-Gil, J.C., Quesada, H., Julve, J., Martin-Campos, J.M., Cedo, L., Blanco-Vaca, F., Sitosterolemia: diagnosis, investigation, and management. Curr. Atheroscler. Rep., 16, 2014 424.
8. [8] Hansel, B., Carrie, A., Brun-Druc, N., Leclert, G., Chantepie, S., Coiffard, A.S., Kahn, J.F., Chapman, M.J., Bruckert, E., Premature atherosclerosis is not systematic in phytosterolemic patients: severe hypercholesterolemia as a confounding factor in five subjects. Atherosclerosis 234 (2014), 162–168.
9. [9] Genser, B., Silbernagel, G., De Backer, G., Bruckert, E., Carmena, R., Chapman, M.J., Deanfield, J., Descamps, O.S., Rietzschel, E.R., Dias, K.C., Marz, W., Plant sterols and cardiovascular disease: a systematic review and meta-analysis. Eur. Heart J. 33 (2012), 444–451.
10. [10] Gylling, H., Clinical utility of serum markers of cholesterol absorption and synthesis. Curr. Opin. Lipidol. 25 (2014), 207–212.
11. [11] Gylling, H., Plat, J., Turley, S., Ginsberg, H.N., Ellegard, L., Jessup, W., Jones, P.J., Lütjohann, D., Maerz, W., Masana, L., Silbernagel, G., Staels, B., Boren, J., Catapano, A.L., De Backer, G., Deanfield, J., Descamps, O.S., Kovanen, P.T., Riccardi, G., Tokgozoglu, L., Chapman, M.J., Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis 232 (2014), 346–360.
12. [12] Matthan, N.R., Zhu, L., Pencina, M., D'Agostino, R.B., Schaefer, E.J., Lichtenstein, A.H., Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants. J. Am. Heart Assoc., 2, 2013, e005066.
13. [13] Silbernagel, G., Chapman, M.J., Genser, B., Kleber, M.E., Fauler, G., Scharnagl, H., Grammer, T.B., Boehm, B.O., Makela, K.M., Kahonen, M., Carmena, R., Rietzschel, E.R., Bruckert, E., Deanfield, J.E., Miettinen, T.A., Raitakari, O.T., Lehtimäki, T., Marz, W., High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysis. J. Am. Coll. Cardiol. 62 (2013), 291–299.
14. [14] Teupser, D., Baber, R., Ceglarek, U., Scholz, M., Illig, T., Gieger, C., Holdt, L.M., Leichtle, A., Greiser, K.H., Huster, D., Linsel-Nitschke, P., Schafer, A., Braund, P.S., Tiret, L., Stark, K., Raaz-Schrauder, D., Fiedler, G.M., Wilfert, W., Beutner, F., Gielen, S., Grosshennig, A., Konig, I.R., Lichtner, P., Heid, I.M., Kluttig, A., El Mokhtari, N.E., Rubin, D., Ekici, A.B., Reis, A., Garlichs, C.D., Hall, A.S., Matthes, G., Wittekind, C., Hengstenberg, C., Cambien, F., Schreiber, S., Werdan, K., Meitinger, T., Loeffler, M., Samani, N.J., Erdmann, J., Wichmann, H.E., Schunkert, H., Thiery, J., Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ. Cardiovasc. Genet. 3 (2010), 331–339.
15. [15] Grundy, S.M., Plasma noncholesterol sterols as indicators of cholesterol absorption. J. Lipid Res. 54 (2013), 873–875.
16. [16] Brown, A.J., Ikonen, E., Olkkonen, V.M., Cholesterol precursors: more than mere markers of biosynthesis. Curr. Opin. Lipidol. 25 (2014), 133–139.
17. [17] Gill, S., Stevenson, J., Kristiana, I., Brown, A.J., Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab. 13 (2011), 260–273.
18. [18] Gylling, H., Hallikainen, M., Rajaratnam, R.A., Simonen, P., Pihlajamäki, J., Laakso, M., Miettinen, T.A., The metabolism of plant sterols is disturbed in postmenopausal women with coronary artery disease. Metabolism 58 (2009), 401–407.
19. [19] Kempen, H.J., de Knijff, P., Boomsma, D.I., van der Voort, H.A., Gevers Leuven, J.A., Havekes, L., Plasma levels of lathosterol and phytosterols in relation to age, sex, anthropometric parameters, plasma lipids, and apolipoprotein E phenotype, in 160 Dutch families. Metabolism 40 (1991), 604–611.
20. [20] Miettinen, T.A., Tilvis, R.S., Kesäniemi, Y.A., Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am. J. Epidemiol. 131 (1990), 20–31.
21. [21] Simonen, M., Männisto, V., Leppänen, J., Kaminska, D., Karja, V., Venesmaa, S., Käkelä, P., Kuusisto, J., Gylling, H., Laakso, M., Pihlajamäki, J., Desmosterol in human nonalcoholic steatohepatitis. Hepatology 58 (2013), 976–982.
22. [22] Jansen, M., Wang, W., Greco, D., Bellenchi, G.C., di Porzio, U., Brown, A.J., Ikonen, E., What dictates the accumulation of desmosterol in the developing brain?. FASEB J. 27 (2013), 865–870.
23. [23] Kallio, M.J., Siimes, M.A., Perheentupa, J., Salmenperä, L., Miettinen, T.A., Cholesterol and its precursors in human milk during prolonged exclusive breast-feeding. Am. J. Clin. Nutr. 50 (1989), 782–785.
24. [24] Wang, W., Mutka, A.L., Zmrzljak, U.P., Rozman, D., Tanila, H., Gylling, H., Remes, A.M., Huttunen, H.J., Ikonen, E., Amyloid precursor protein alpha- and beta-cleaved ectodomains exert opposing control of cholesterol homeostasis via SREBP2. FASEB J. 28 (2014), 849–860.
25. [25] Barone, E., Di Domenico, F., Butterfield, D.A., Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets. Biochem. Pharmacol. 88 (2014), 605–616.
26. [26] Björkhem, I., Diczfalusy, U., Oxysterols: friends, foes, or just fellow passengers?. Arterioscler. Thromb. Vasc. Biol. 22 (2002), 734–742.
27. [27] Babiker, A., Andersson, O., Lindblom, D., van der Linden, J., Wiklund, B., Lütjohann, D., Diczfalusy, U., Björkhem, I., Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J. Lipid Res. 40 (1999), 1417–1425.
28. [28] Lütjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Siden, A., Diczfalusy, U., Björkhem, I., Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 9799–9804.
29. [29] Björkhem, I., Lütjohann, D., Diczfalusy, U., Stahle, L., Ahlborg, G., Wahren, J., Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39 (1998), 1594–1600.
30. [30] Björkhem, I., Meaney, S., Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24 (2004), 806–815.
31. [31] Calkin, A.C., Tontonoz, P., Liver × receptor signaling pathways and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 1513–1518.
32. [32] Bonamassa, B., Moschetta, A., Atherosclerosis: lessons from LXR and the intestine. Trends Endocrinol. Metabol. 24 (2013), 120–128.
33. [33] Olkkonen, V.M., Lehto, M., Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis. Ann. Med. 36 (2004), 562–572.
34. [34] van Reyk, D.M., Brown, A.J., Hult'en, L.M., Dean, R.T., Jessup, W., Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Rep. 11 (2006), 255–262.
35. [35] Olkkonen, V.M., Macrophage oxysterols and their binding proteins: roles in atherosclerosis. Curr. Opin. Lipidol. 23 (2012), 462–470.
36. [36] Lordan, S., Mackrill, J.J., O'Brien, N.M., Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J. Nutr. Biochem. 20 (2009), 321–336.
37. [37] Boenzi, S., Deodato, F., Taurisano, R., Martinelli, D., Verrigni, D., Carrozzo, R., Bertini, E., Pastore, A., Dionisi-Vici, C., Johnson, D.W., A new simple and rapid LC-ESI–MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease. Clin. Chim. Acta 437 (2014), 93–100.
38. [38] Jiang, X., Sidhu, R., Porter, F.D., Yanjanin, N.M., Speak, A.O., te Vruchte, D.T., Platt, F.M., Fujiwara, H., Scherrer, D.E., Zhang, J., Dietzen, D.J., Schaffer, J.E., Ory, D.S., A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J. Lipid Res. 52 (2011), 1435–1445.
39. [39] Klinke, G., Rohrbach, M., Giugliani, R., Burda, P., Baumgartner, M.R., Tran, C., Gautschi, M., Mathis, D., Hersberger, M., LC-MS/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases. Clin. Biochem. 48 (2015), 596–602.
40. [40] Porter, F.D., Scherrer, D.E., Lanier, M.H., Langmade, S.J., Molugu, V., Gale, S.E., Olzeski, D., Sidhu, R., Dietzen, D.J., Fu, R., Wassif, C.A., Yanjanin, N.M., Marso, S.P., House, J., Vite, C., Schaffer, J.E., Ory, D.S., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci. Transl. Med., 2, 2010, 56ra81.
41. [41] Björkhem, I., Hansson, M., Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem. Biophys. Res. Commun. 396 (2010), 46–49.
42. [42] Björkhem, I., Diczfalusy, U., Lövgren-Sandblom, A., Starck, L., Jonsson, M., Tallman, K., Schirmer, H., Ousager, L.B., Crick, P.J., Wang, Y., Griffiths, W.J., Guengerich, F.P., On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO. J. Lipid Res. 55 (2014), 1165–1172.
43. [43] Pajares, S., Arias, A., Garcia-Villoria, J., Macias-Vidal, J., Ros, E., de Las Heras, J., Giros, M., Coll, M.J., Ribes, A., Cholestane-3beta,5alpha,6beta-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency. J. Lipid Res. 56 (2015), 1926–1935.
44. [44] Descamps, O.S., De Sutter, J., Guillaume, M., Missault, L., Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?. Atherosclerosis 217 (2011), 308–321.